ILCA Virtual. 11-13 September. For everyone researching and treating liver cancer.
Enjoy a daily live stream, 50+ sessions of original thinking, inspiration and complimentary access to exclusive on-demand sessions
We’re setting out to bring the global liver cancer community together over the week leading up to the live sessions on 11-13 September. It is extremely encouraging to already have a great level of support and participation from across the ILCA community. Many colleagues from around the world are getting ready to tune in to learn, be inspired, connect with the global community and be part of something.
We’re aiming to bring the very best in Liver Cancer to a broad and diverse audience, united in the dedication to improving patient care. We’ve prepared a short video to give you a flavour of what’s in store for you when you join us, have a look at it below and let us know. We have a few more lined up, so be sure to look out for those too.
Today, our educational programme has been finalised and we’re already working hard with speakers to make sure that their great knowledge and insights convey well in the virtual setting. They are bringing their stories, breakthroughs and inspirational approaches to ILCA. The conference programme will feature a combination of live and on-demand sessions. We’ll be releasing exclusive on-demand sessions early, from 7 September on, highlighting the voices that need to be heard. You can read more about the sessions below, or you can click here to view the entire conference programme. The full ILCA Virtual conference will remain available to watch after 13 September, keeping the content alive.
Exclusive on-demand sessions, available from 7 September on
Symposium: Sequencing and Stratification of Systemic Therapy in HCC
Stephen Chan, Hong Kong
Department of Clinical Oncology, The Chinese University of Hong Kong
The Second Line in a Dynamic Landscape
Basic Science Symposium: Molecular pathogenesis and targets in cholangiocarcinoma
Gregory Gores, USA
Executive Dean for Research, Physician Scientist
Pathogenesis and molecular drivers of cholangiocarcinoma
Symposium: Cancer care beyond anti-tumor therapy
Maria Die Trill, Spain
Coordinator of the Psycho-Oncology Unit of the Hospital Universitario Gregorio Marañón and Assistant Professor at the School of Psychology, Universidad Complutense of Madrid, Spain
Psychooncology: Basic Principles applied to liver cancer
ILCA guidance symposium: Systemic Therapy Guidance and Biomarker Development in HCC
Katie Kelley, USA
Associate Professor of Clinical Medicine, Department of Medicine (Hematology/Oncology), UCSF
Systemic Therapy Guidance
Single Topic Workshop: Molecular diversity and systemic treatment for HCC and Surgery in the management of HCC: role of surgeons and of the radiologist
Riccardo Lencioni, Italy
Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation at Pisa University Hospital in Italy
Surgery in the management of HCC: role of surgeons and of the radiologists
Participants will be able to write and send their questions while watching the on-demand symposia.
These questions will be answered by the symposia speakers during the live Symposium Question & Answers sessions scheduled from 11th to 13th September 2020 (LIVE sessions programme)
#ILCA20Virtual has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s).